Qilian International Holding Group Limited (QLI)

NASDAQ: QLI · IEX Real-Time Price · USD
0.690
+0.080 (13.10%)
At close: Mar 28, 2024, 3:57 PM
1.040
+0.350 (50.75%)
After-hours: Mar 28, 2024, 7:59 PM EDT
13.10%
Market Cap 24.66M
Revenue (ttm) 46.47M
Net Income (ttm) -7.78M
Shares Out 35.75M
EPS (ttm) -0.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,431,113
Open 0.590
Previous Close 0.610
Day's Range 0.570 - 0.690
52-Week Range 0.355 - 1.350
Beta 1.37
Analysts n/a
Price Target n/a
Earnings Date Apr 17, 2024

About QLI

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solu... [Read more]

Sector Healthcare
IPO Date Jan 12, 2021
Employees 298
Stock Exchange NASDAQ
Ticker Symbol QLI
Full Company Profile

Financial Performance

Financial Statements

News

Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule

JIUQUAN, China, Jan. 12, 2024 /PRNewswire/ -- Qilian International Holding Group Limited (NASDAQ:  QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, t...

2 months ago - PRNewsWire

Qilian International Holding Group Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

JIUQUAN, China , July 17, 2023 /PRNewswire/ -- Qilian International Holding Group Ltd (NASDAQ: QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, receiv...

9 months ago - PRNewsWire

Qilian Received a Letter from Nasdaq Related to Regain Compliance

JIUQUAN, China , April 26, 2023 /PRNewswire/ -- Qilian International Holding Group Limited (NASDAQ: QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, p...

1 year ago - PRNewsWire

Qilian Received Notification of Deficiency from Nasdaq Related to not timely Filing of Annual Report Form 20-F

JIUQUAN, China , Feb. 23, 2023 /PRNewswire/ -- Qilian International Holding Group Ltd (NASDAQ: QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, today ...

1 year ago - PRNewsWire

Qilian International Holding Group Ltd Declares Special Cash Dividends to Shareholders

JIUQUAN, China , Feb. 16, 2023 /PRNewswire/ -- Qilian International Holding Group Ltd (the "Company" or Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, announced today t...

1 year ago - PRNewsWire

Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022

JIUQUAN, China , Sept. 30, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announc...

1 year ago - PRNewsWire

Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial Results

JIUQUAN, China, Feb. 11, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company", "Qilian International", "we", "our" or "us"), a China-based pharmaceutical and ch...

2 years ago - PRNewsWire

Qilian International Holding Group Limited Receives Approval for the Sale of its Newly Developed Nitrofurantoin Enteric-coated Tablets

JIUQUAN, China, Jan. 19, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company", "Qilian International", "we", "our" or "us"), a China-based pharmaceutical and ch...

2 years ago - PRNewsWire

Qilian International Holding Group Limited Releases 2022 Chairman Letter

JIUQUAN, China, Jan. 11, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company", "Qilian International", "we", "our" or "us"), a China-based pharmaceutical and ch...

2 years ago - PRNewsWire

Qilian International Holding Group Limited Announces Inclusion of Gan Di Xin® and Qilian Shan® Oxytetracycline into List for Development of Leading Enterprises with Large Varieties and Brands of Pharmaceuticals of Gansu Province

JIUQUAN, China, Nov. 23, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced...

2 years ago - PRNewsWire

Qilian International Holding Group Limited Announces Initiation of Development of New Drug for Gastric Cancer Prevention

JIUQUAN, China, Nov. 15, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that ...

2 years ago - PRNewsWire

Qilian International Holding Group Limited Donates Pharmaceutical Products Gan Di Xin® Worth RMB500,000 and Other Materials to Help Fight Local COVID-19 Epidemic

JIUQUAN, China, Nov. 1, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that r...

2 years ago - PRNewsWire

Qilian International Holding Group Limited Completes Phase One of Its Expansion of New Organic Fertilizer Production Facility and Puts It into Production

JIUQUAN, China, Oct. 26, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced...

2 years ago - PRNewsWire

Qilian International Holding Group Limited Received Approval for Oxytetracycline API Export to Egypt

JIUQUAN, China, Oct. 13, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that ...

2 years ago - PRNewsWire

Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2021

Jiuquan, China, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today anno...

2 years ago - GlobeNewsWire

Qilian International Holding Group Limited Signs Agreement with District Government, Settling the Project in Local High-tech Zone

Jiuquan, China, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today annou...

2 years ago - GlobeNewsWire

Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in Chongqing

Jiuquan, China, July 09, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today annou...

2 years ago - GlobeNewsWire

Qilian International Holding Group Limited Announces Inclusion of 16 Products into China's National Reimbursement Drugs List

Jiuquan, China, April 13, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today anno...

3 years ago - GlobeNewsWire

Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results

Jiuquan, China, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today annou...

3 years ago - GlobeNewsWire

Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021

Jiuquan, China, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today annou...

3 years ago - GlobeNewsWire

Univest Securities, LLC. Announces Closing of IPO for its Client Qilian International Holding Group Limited (Nasdaq: QLI)

New York, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, is a full-service investment bank and securities broker-dealer firm based in New York, toda...

3 years ago - GlobeNewsWire

Qilian International Holding Group Limited Announces Closing of Initial Public Offering

Jiuquan, China, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, today annou...

3 years ago - GlobeNewsWire

Qilian International Holding Group Limited Announces Pricing of Initial Public Offering

Jiuquan, China, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced the prici...

3 years ago - GlobeNewsWire